Figure 1A revealed that GAS5 levels in paired adjacent normal tissues were remarkably higher than levels observed in NSCLC tissues. Expression levels of GAS5 were negatively associated with tumor status progression (Table 1) (p = 0.017*), tumor size (p = 0.036*) and lymphatic metastasis (p = 0.028*) (Table 1). Here, GAS5 is linked to non-small cell lung carcinoma.